Inhibrx Biosciences, Stock Market Value
| INBX Stock | USD 24.45 0.83 3.51% |
| Symbol | Inhibrx |
Inhibrx Biosciences, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibrx Biosciences,. If investors know Inhibrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibrx Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inhibrx Biosciences, is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Inhibrx Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx Biosciences,'s market value can be influenced by many factors that don't directly affect Inhibrx Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Inhibrx Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Inhibrx Biosciences, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inhibrx Biosciences,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inhibrx Biosciences,.
| 04/21/2025 |
| 07/20/2025 |
If you would invest 0.00 in Inhibrx Biosciences, on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding Inhibrx Biosciences, or generate 0.0% return on investment in Inhibrx Biosciences, over 90 days. Inhibrx Biosciences, is related to or competes with Keros Therapeutics, Janux Therapeutics, Fennec Pharmaceuticals, Edgewise Therapeutics, Harmony Biosciences, Kymera Therapeutics, and Iteos Therapeutics. Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic ca... More
Inhibrx Biosciences, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inhibrx Biosciences,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inhibrx Biosciences, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.39 | |||
| Information Ratio | 0.259 | |||
| Maximum Drawdown | 15.98 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 7.99 |
Inhibrx Biosciences, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inhibrx Biosciences,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inhibrx Biosciences,'s standard deviation. In reality, there are many statistical measures that can use Inhibrx Biosciences, historical prices to predict the future Inhibrx Biosciences,'s volatility.| Risk Adjusted Performance | 0.2825 | |||
| Jensen Alpha | 1.12 | |||
| Total Risk Alpha | 0.607 | |||
| Sortino Ratio | 0.3061 | |||
| Treynor Ratio | 3.06 |
Inhibrx Biosciences, Backtested Returns
Inhibrx Biosciences, is not too volatile given 3 months investment horizon. Inhibrx Biosciences, holds Efficiency (Sharpe) Ratio of 0.32, which attests that the entity had a 0.32 % return per unit of risk over the last 3 months. We have analyzed thirty different technical indicators, which can help you to evaluate if expected returns of 1.3% are justified by taking the suggested risk. Use Inhibrx Biosciences, Downside Deviation of 3.39, risk adjusted performance of 0.2825, and Market Risk Adjusted Performance of 3.07 to evaluate company specific risk that cannot be diversified away. Inhibrx Biosciences, holds a performance score of 25 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Inhibrx Biosciences,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Inhibrx Biosciences, is expected to be smaller as well. Use Inhibrx Biosciences, potential upside, and the relationship between the total risk alpha and kurtosis , to analyze future returns on Inhibrx Biosciences,.
Auto-correlation | 0.83 |
Very good predictability
Inhibrx Biosciences, has very good predictability. Overlapping area represents the amount of predictability between Inhibrx Biosciences, time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inhibrx Biosciences, price movement. The serial correlation of 0.83 indicates that around 83.0% of current Inhibrx Biosciences, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 14.37 |
Inhibrx Biosciences, lagged returns against current returns
Autocorrelation, which is Inhibrx Biosciences, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inhibrx Biosciences,'s stock expected returns. We can calculate the autocorrelation of Inhibrx Biosciences, returns to help us make a trade decision. For example, suppose you find that Inhibrx Biosciences, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Inhibrx Biosciences, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inhibrx Biosciences, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inhibrx Biosciences, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inhibrx Biosciences, stock over time.
Current vs Lagged Prices |
| Timeline |
Inhibrx Biosciences, Lagged Returns
When evaluating Inhibrx Biosciences,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inhibrx Biosciences, stock have on its future price. Inhibrx Biosciences, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inhibrx Biosciences, autocorrelation shows the relationship between Inhibrx Biosciences, stock current value and its past values and can show if there is a momentum factor associated with investing in Inhibrx Biosciences,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Inhibrx Stock Analysis
When running Inhibrx Biosciences,'s price analysis, check to measure Inhibrx Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences, is operating at the current time. Most of Inhibrx Biosciences,'s value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences,'s price. Additionally, you may evaluate how the addition of Inhibrx Biosciences, to your portfolios can decrease your overall portfolio volatility.